Geron Corporation Investors Urged to Seek Expert Guidance as Deadline Looms in Securities Lawsuit

ROSEN SKILLED INVESTOR COUNSEL ENCOURAGES GERON CORPORATION INVESTORS TO SECURE COUNSEL BEFORE IMPENDING DEADLINE IN CLASS ACTION

Houston, TX - Rosen Law Firm, a global investor rights law firm, reminds purchasers of Geron Corporation (NASDAQ: GERN) securities between November 3, 2016 and April 14, 2022, inclusive (the "Class Period"), of the important April 25, 2022 lead plaintiff deadline in the securities class action lawsuit filed by the firm.

On April 14, 2022, Geron Corporation announced that it would be acquired by Kura Oncology, Inc. for approximately $23.50 per share. The Rosen Law Firm encourages investors who purchased Geron Corporation securities during the Class Period to secure counsel to protect their investment.

According to the lawsuit, throughout the Class Period, the defendants made false and misleading statements and failed to disclose material information to the public, causing Geron Corporation's stock to trade at artificially inflated prices.

The Rosen Law Firm's investigation is focused on whether Geron Corporation's officers and directors failed to disclose material information to the public, violating federal securities laws. Specifically, the lawsuit alleges that the defendants made false and misleading statements and failed to disclose material information to the public, causing Geron Corporation's stock to trade at artificially inflated prices.

If you purchased Geron Corporation securities during the Class Period, you may be entitled to participate in this action. To be a part of this action, you must seek appointment as lead plaintiff by April 25, 2022. The Rosen Law Firm encourages investors to visit the firm's website at http://www.rosenlegal.com or contact the firm to discuss their options.

Rosen Law Firm represents investors worldwide, focusing exclusively on securities based cases and class actions. If you wish to join the litigation, please contact the firm to learn more about the case. The Rosen Law Firm's investigation is ongoing, and information is being gathered to determine the most effective way to protect investor interests.